Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 4/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | CASP7 | P55210 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 7/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrogen SCHEMBL28695213 | 0.96 | MAPK1 (0.56) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL397773 | 0.82 | MAPK1 (0.77) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL4793372 | 0.78 | MAPK1 (0.60) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL297021 | 0.78 | MAPK1 (0.60) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL728448 | 0.78 | MEN1 (0.61) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL12205174 | 0.78 | MAPK1 (0.60) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL973213 | 0.78 | MAPK1 (0.60) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL373368 | 0.78 | MAPK1 (0.60) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL950729 | 0.78 | MAPK1 (0.60) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 | |
| SCHEMBL355102 | 0.78 | MAPK1 (0.60) | MAPK1L3MBTL1ALDH1A1TDP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119100999-A | Synthesis method of plant extract cardanol modified benzotriazole ultraviolet absorber | 烟台新特路新材料科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-110305018-A | A kind of preparation method of the bromo- 2- fluoronitrobenzene of 3- | 浙江普洛家园药业有限公司 | 2019-10-08 | — | — | CN | claimed |
| CN-109467535-A | A kind of preparation method of Fenbendazole | 江苏宝众宝达药业有限公司 | 2019-03-15 | — | — | CN | claimed |
| CN-105669520-B | O-phenylenediamine class selectivity histon deacetylase (HDAC) inhibitor containing tryptophan basic framework and its preparation method and application | 山东大学 | 2018-10-30 | — | — | CN | claimed |
| CN-105669520-A | Tryptophan basic skeleton-containing o-phenylenediamine selective histone deacetylase inhibitor and its preparation method and use | 山东大学 | 2016-06-15 | — | — | CN | claimed |
| CN-103728294-B | Bisbenzimidazole connection carbazole compound is for specific binding nucleic acid G-tetra-chain body structures and in the application of antineoplastic | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2016-05-11 | — | — | CN | claimed |
| CN-103728294-A | Applications of bisbenzimidazole bicarbazole compound in specific binding nucleic acid G-quadruplex structure and anti-tumor drug | CHINESE ACAD INST CHEMISTRY | 2014-04-16 | — | — | CN | claimed |
| CN-119100999-A | Synthesis method of plant extract cardanol modified benzotriazole ultraviolet absorber | 烟台新特路新材料科技有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-111164074-B | Heat shock protein 90 inhibitors | 台北医学大学 | 2024-02-02 | — | — | CN | disclosed |
| CN-115433092-A | Synthesis process of 4-bromo o-phenylenediamine | 苏州信礼发医药技术有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-110305018-B | Preparation method of 3-bromo-2-fluoronitrobenzene | 浙江普洛家园药业有限公司 | 2022-07-15 | — | — | CN | disclosed |
| WO-2021138392-A1 | AMINOPYRIMIDINE COMPOUNDS | TYRA BIOSCIENCES, INC. (US) | 2021-07-08 | — | — | WO | disclosed |
| CN-111164074-A | Heat shock protein 90 inhibitor | 台北医学大学 | 2020-05-15 | — | — | CN | disclosed |
| CN-101472585-B | Antibacterial compositions | BIOTA EUROPE LTD | 2013-12-04 | — | — | CN | disclosed |
| CN-101445469-B | Inhibitors of histone deacetylase | METHYLGENE INC | 2013-02-13 | — | — | CN | disclosed |
| EP-2432779-A1 | BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES | Exelixis, Inc. (US) | 2012-03-28 | — | — | EP | disclosed |
| CN-102170882-A | Compositions and methods of treating amyloid disease | TREVENTIS CORP | 2011-08-31 | — | — | CN | disclosed |
| WO-2010135524-A1 | BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES | EXELIXIS, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| EP-1497287-B1 | Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2010-11-24 | — | — | EP | disclosed |
| CN-101389630-A | Protein kinase inhibitors | ABBOTT LAB (US) | 2009-03-18 | — | — | CN | disclosed |